NCT00831844 2015-03-30Cixutumumab in Treating Patients With Relapsed or Refractory Solid TumorsNational Cancer Institute (NCI)Phase 2 Completed116 enrolled 8 charts
NCT00006102 2013-02-05Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's LymphomaNational Cancer Institute (NCI)Phase 2 Completed200 enrolled